Long-term Safety of Risankizumab in Plaque Psoriasis Long-term Safety of Risankizumab in Plaque Psoriasis

The safety findings in this analysis support risankizumab as a long-term treatment option for patients with moderate-to-severe psoriasis.The British Journal of Dermatology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news